Episode 5: In Silico Clinical Trials
Drug and device testing is long and costly, with few successes. In silico trials use virtual patients to speed development, cut costs, reduce animal testing, and enable faster, safer access to new treatments.
Before a drug or medical device can be used, it undergoes extensive pre-clinical and clinical trials to ensure safety and effectiveness. This process can take years and cost millions, with only 1 in 10 drugs reaching the market. However, computer-simulated trials, or in silico trials, can streamline this process by using virtual populations based on real patients. These trials reduce the need for animal and human testing, speed up innovation, and promote early patient access, emphasizing collaboration among various stakeholders.
If you want to know more about in silico medicine, listen to the podcast The Digital Twin Theory by VPH on Spotify.
Related media
Episode 10- With great power comes great responsibility
In silico medicine is reshaping healthcare through computer models, but trust and equity are key. Collaboration among scientists, clinicians, patients, and policymakers ensures this digital future serves everyone.
Discover more
Episode 9: Beating childhood cancer with in silico medicine
Childhood cancer remains a global challenge. In the 9th Code and Cure video, we explore how in silico models simulate tumour responses to chemotherapy, helping doctors tailor safer, more effective treatments.
Discover more
Episode 8: Digital hearts – The future of cardiovascular medicine
Heart disease is the leading cause of death worldwide. In silico medicine lets clinicians virtually test pacemakers and occluders, optimising device choice and enhancing surgical precision.
Discover more